로딩 중…
지수 로딩 중…
Fulgent Genetics, Inc.
FLGT· NASDAQ· Health Care· Health Care Equipment & Services
$19.29-6.45%
2026-11-02
Financials
Valuation Metrics
Fulgent Genetics, Inc.'s Market Cap is $531M. At end of 2025 it was $809M. Ranked #2692 of 3,118 in US market (top 86%), #1165 of 1,474 on NASDAQ (top 79%), #168 of 203 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $531M | US#2,692/3,118 Sec#168/203 |
| Revenue | $324M | US#2,394/3,118 Sec#155/203 |
| Net Income | $-84M | US—/3,118 Sec—/203 |
| Total Assets | $1.09B | US#2,431/3,118 Sec#126/203 |
| Net Assets | $1.00B | US#1,755/3,118 Sec#94/203 |
| Value | ||
| P/B | 0.53x | US#116/3,118 Sec#7/203 |
| P/S | 1.64x | US#1,169/3,118 Sec#80/203 |
| FCF Yield | -19.55% | US—/3,118 Sec—/203 |
| Profitability | ||
| ROE | -8.42% | US#2,333/3,118 Sec#135/203 |
| ROA | -7.75% | US#2,606/3,118 Sec#152/203 |
| Op. Margin | -37.08% | US#2,632/3,118 Sec#174/203 |
| Revenue Growth | 6.83% | US#1,570/3,118 Sec#114/203 |
| Financial Health | ||
| Debt Ratio | 9.31% | US#100/3,118 Sec#5/203 |
| Total Debt | $9M | US#2,826/3,118 Sec#188/203 |
| FCF | $-104M | US#2,638/3,118 Sec#189/203 |
| Cash | $26M | US#2,784/3,118 Sec#183/203 |
| Current Ratio | 6.34x | US#375/3,118 Sec#28/203 |
| Performance | ||
| 1Y Return | -14.08% | US#2,089/3,118 Sec#147/203 |
| 1M Return | -10.20% | US#2,267/3,118 Sec#165/203 |
| From 52W High | -37.85% | US#2,108/3,118 Sec#155/203 |
| 1Y MDD | -55.30% | US#2,594/3,118 Sec#164/203 |
| Trading | ||
| Volume | 332,604 shares | US#2,734/3,118 Sec#187/203 |
| Trading Value | $7M | US#2,746/3,118 Sec#179/203 |
| Per Share | ||
| EPS | $-3.07 | US—/3,118 Sec—/203 |
| BPS | $36.40 | US#712/3,118 Sec#47/203 |